GSK-3β inhibitor 25
GSK-3β inhibitor 25 (Compound 6h) exhibits a weak inhibitory activity against GSK-3β wih an IC50>100 μM[1].
Product Specifications
CAS Number
[75620-25-6]
UNSPSC
12352005
Target
GSK-3
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Metabolic Disease; Neurological Disease
Smiles
O=C1N(CC2=CC=CC=C2)C3=C(SCC1)C=CC=C3
Molecular Formula
C16H15NOS
Molecular Weight
269.36
References & Citations
[1]Zhang P, et al., Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β) . Eur J Med Chem. 2013 Mar;61:95-103.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
148020 100 µg
TAS1R2, Control Peptide (Taste Receptor Type 1 Member 2, T1R2, TR2, G-protein Coupled Receptor 71, GPR71, Sweet Taste Receptor T1R2)
Ask
View Details